Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02227329 · ClinicalTrials.gov registry record · Phase 1
Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition
A Phase 1 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 1
- Development phase
- 39
- Enrollment target
NCT02227329: Clinical Trial Phase 1 study, sponsored by Mayo Clinic.
NCT02227329 is a Phase 1 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02227329, a Phase 1 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 39 participants
- Enrollment target
Study Summary
This study is being implemented to identify the role of prophylactic use of ethanol lock in adult patients on home parenteral nutrition (HPN). Central catheter related blood stream infection is a major complication in patients on HPN. The investigators hypothesize that the prophylactic use of ELT will decrease the number of catheter related blood stream infections compared to the control group. The investigators further hypothesize that with the introduction of prophylactic ELT, the number of infections will decrease.
Interventions
- DRUG Ethanol
- DRUG Normal Saline
- DRUG Heparin Lock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02227329
The ClinicalTrials.gov registry entry for NCT02227329 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ethanol is the first listed.
NCT02227329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02227329 about?
NCT02227329 is a clinical study titled "Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition". This study is being implemented to identify the role of prophylactic use of ethanol lock in adult patients on home parenteral nutrition (HPN). Central catheter related blood stream infection is a major complication in patients on HPN. The investigators hypothesize that the prophylactic use of ELT wi...
What is the current status of trial NCT02227329?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2014-07. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02227329?
The interventions under investigation include: Ethanol (DRUG), Normal Saline (DRUG), Heparin Lock (DRUG).
Who is sponsoring clinical trial NCT02227329?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.